Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04852848 · ClinicalTrials.gov registry record · NA

Creating a Sustainable Infrastructure for SARS-CoV-2 Testing (COVID-19) at Syringe Exchange Programs

A NA study, sponsored by University of Oregon.

Completed
Registry status
NA
Development phase
205
Enrollment target

NCT04852848 is a NA study that has completed, run by University of Oregon. The registered enrollment target is 205 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04852848, a NA study, has completed, sponsored by University of Oregon.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target

Study Summary

PWIDs have been an underserved population in the context of the current pandemic; thus, little is known about the prevalence of COVID-19 and the acceptability and possible reach of testing for COVID-19 among PWIDs. To address this gap, this study leverages a current partnership with HIV Alliance (HIVA) in Oregon and our Community and Scientific Advisory Board to support implementation and sustainability of a COVID-19 testing program. Specifically, we will use community-based participatory approaches to develop, implement, and evaluate a COVID-19 testing program offered through HIVA's Syringe Services Programs (SSP), a natural point of care for PWIDs. The COVID-19 testing program will include procedures for sample collection, transmission of specimens to the University of Oregon CLIA-certified laboratory, and results reporting. Our clinical trial is a randomized control trial focused improving the uptake of testing through a motivational enhancement intervention: Connect2Test.

Interventions

  • BEHAVIORAL Connect2Test Intervention

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2021-04-14
Est. Completion 2021-06-30
Phase NA

Sponsor

University of Oregon

63 total trials

What the Registry Record Tells You About NCT04852848

The ClinicalTrials.gov registry entry for NCT04852848 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 205 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oregon, which has 63 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Connect2Test Intervention is the first listed.

NCT04852848 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04852848 about?

NCT04852848 is a clinical study titled "Creating a Sustainable Infrastructure for SARS-CoV-2 Testing (COVID-19) at Syringe Exchange Programs". PWIDs have been an underserved population in the context of the current pandemic; thus, little is known about the prevalence of COVID-19 and the acceptability and possible reach of testing for COVID-19 among PWIDs. To address this gap, this study leverages a current partnership with HIV Alliance (HI...

What is the current status of trial NCT04852848?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2021-04-14. Estimated completion is 2021-06-30.

What interventions are being tested in trial NCT04852848?

The interventions under investigation include: Connect2Test Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04852848?

This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.